Use of GLP-1 analogs and derivative adminstered peripherally in regulation of obesity
US6583111B1 · kind B1 · utility
183Cited by
4References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 2000 |
| Grant date | Jun 24, 2003 |
| Priority date | — |
| Expiry date | Jun 1, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates the use of glucagon-like peptides such as GLP-1, a GLP-1 analog, or a GLP-1 derivative in methods and compositions for reducing body weight.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.